Category Archives: HIV care & treatment

Kaiser Permanente reverses decision to move HIV meds to specialty tier in California, reduces out-of-pocket cost for patients


SAN FRANCISCO, February 23, 2015.  Project Inform and San Francisco AIDS Foundation applaud Kaiser Permanente’s decision last week to revise its 2015 drug categorization which put all HIV medications in the highest specialty tier in the California marketplace. Pricing HIV medications in this tier would have…Read More

Project Inform highlights HIV and hepatitis C components of President’s 2016 Budget Request


On February 2, 2015 the President released his budget request for Fiscal Year (FY) 2016, calling for overall funding increases, including flat funding and modest, but important, increases for viral hepatitis and HIV programs. Of note in the budget were the modest increases for the Centers…Read More

Reported cases of sexual transmission of hepatitis C in gay men taking PrEP in a San Francisco sexual health setting

Hepatitis C (HCV) is a blood-borne viral infection that is primarily transmitted through the sharing of injection drug equipment. Historically, sexual transmission of HCV has been considered a low-risk activity overall, but research beginning in the early 2000s has found it to be more common in…Read More

FDA approves two new fixed-dose combo pills to treat HIV infection


On January 29, 2015, the FDA approved two new combination pills for treating HIV infection. The first is called Prezcobix, which contains the protease inhibitor Prezista (darunavir) and the booster drug Tybost (cobicistat). The second is Evotaz, which contains the protease inhibitor Reyataz (atazanavir) along with…Read More

Much more is needed beyond CA Governor’s proposed investment in hepatitis C and HIV


FOR IMMEDIATE RELEASE:    January 22, 2015 Contact:  Anne Donnelly,, (415) 640-6103; Emalie Huriaux,,  (415) 580-7301   Project Inform Acknowledges Governor Brown’s Proposed Investment in Hepatitis C and HIV, But Much More is Needed to Address These Epidemics and Promote Public Health SAN FRANCISCO, CA –…Read More

Project Inform helps lead effort to “Get to Zero” in San Francisco


San Francisco leads US cities in its progress against HIV. Higher percentages of HIV-positive people know their status, are linked to care and treatment and are virally suppressed than in the rest of the nation. Additionally, newly diagnosed cases of HIV infection have declined significantly in…Read More

Two new single tablet regimens for treating HIV in the works


At the very end of 2014, two pharmaceutical companies (Janssen, Gilead) announced their plans for developing two new single tablet regimens (STR) for treating HIV infection. The first includes the protease inhibitor Prezista, and the second includes the NNRTI Edurant (rilpivirine). Both STRs would also include…Read More